| Year |
Citation |
Score |
| 2012 |
Grozav AG, Vaziri SAJ, Eric KR, Grabowski DR, Bukowski RM, Ganapathi MK, Ganapathi RN. Abstract A54: Potential mechanisms of resistance to targeted agents in human clear cell renal cell carcinoma Clinical Cancer Research. 18: A54-A54. DOI: 10.1158/1078-0432.Mechres-A54 |
0.412 |
|
| 2011 |
Grozav AG, Willard BB, Kozuki T, Chikamori K, Micluta MA, Petrescu AJ, Kinter M, Ganapathi R, Ganapathi MK. Tyrosine 656 in topoisomerase IIβ is important for the catalytic activity of the enzyme: Identification based on artifactual +80-Da modification at this site. Proteomics. 11: 829-42. PMID 21280220 DOI: 10.1002/Pmic.201000194 |
0.593 |
|
| 2011 |
Ganapathi MK, Grozav AG, Willard BB, Kozuki T, Chikamori K, Micluta MA, Petrescu A, Kinter M, Ganapathi RN. Abstract 2526: Tyrosine 656 in topoisomerase IIβ is important for the catalytic activity Cancer Research. 71: 2526-2526. DOI: 10.1158/1538-7445.Am2011-2526 |
0.474 |
|
| 2010 |
Chikamori K, Grozav AG, Kozuki T, Grabowski D, Ganapathi R, Ganapathi MK. DNA topoisomerase II enzymes as molecular targets for cancer chemotherapy. Current Cancer Drug Targets. 10: 758-71. PMID 20578986 DOI: 10.2174/156800910793605785 |
0.581 |
|
| 2010 |
Grozav AG, Willard B, Vaziri SA, Koegle ER, Kozuki T, Grabowski DR, Bukowski RM, Ganapathi MK, Ganapathi R. Abstract 1626: Tyrosine phosphorylation of RIN1 modulates the anti-proliferative effects of sorafenib and sunitinib in renal cell carcinoma (RCC) Cancer Research. 70: 1626-1626. DOI: 10.1158/1538-7445.Am10-1626 |
0.599 |
|
| 2009 |
Grozav AG, Willard B, Kinter M, Vaziri SA, Bukowski RM, Rini BI, Ganapathi MK, Ganapathi R. Target identification by phosphoproteomics: RIN1 modulation of sorafenib-induced cytotoxicity in renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e14543. PMID 27963618 DOI: 10.1200/Jco.2009.27.15_Suppl.E14543 |
0.366 |
|
| 2009 |
Grozav AG, Chikamori K, Kozuki T, Grabowski DR, Bukowski RM, Willard B, Kinter M, Andersen AH, Ganapathi R, Ganapathi MK. Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activity. Nucleic Acids Research. 37: 382-92. PMID 19043076 DOI: 10.1093/Nar/Gkn934 |
0.605 |
|
| 2006 |
Chikamori K, Hill JE, Grabowski DR, Zarkhin E, Grozav AG, Vaziri SA, Wang J, Gudkov AV, Rybicki LR, Bukowski RM, Yen A, Tanimoto M, Ganapathi MK, Ganapathi R. Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest. Leukemia. 20: 1809-18. PMID 16932348 DOI: 10.1038/Sj.Leu.2404351 |
0.548 |
|
| 2006 |
Ganapathi M, Chikamori K, Hill J, Grabowski D, Zarkhin E, Grozav A, Vaziri S, Bukowski R, Yen A, Ganapathi R. 493 POSTER Down regulation of topoisomerase IIβ in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest European Journal of Cancer Supplements. 4: 150. DOI: 10.1016/S1359-6349(06)70498-0 |
0.369 |
|
| 2004 |
Grozav AG, Hutson TE, Zhou X, Bukowski RM, Ganapathi R, Xu Y. Rapid analysis of docetaxel in human plasma by tandem mass spectrometry with on-line sample extraction. Journal of Pharmaceutical and Biomedical Analysis. 36: 125-31. PMID 15351056 DOI: 10.1016/J.Jpba.2004.05.014 |
0.487 |
|
| 2004 |
Orban T, Grozav A, Buckys M, Gogonea3 V, Kalafatis4 M. Characterization of the Interaction between Thrombin and a Pentapeptide That Interferes with Anion Binding Exosite I of the Enzyme. Blood. 104: 1719-1719. DOI: 10.1182/Blood.V104.11.1719.1719 |
0.326 |
|
| Show low-probability matches. |